Latest Articlesddd
Friday, August 18, 2025 Solid Earning, revenue growth, President Trump signing crypto bills, and Crispr Therapeutics …
Q & A: Kiniksa Pharmaceuticals Q: Do you have any recent news from Kiniksa Pharmaceuticals? A: …
The root-cause of the stock market’s volatility and inflation does not make sense as we are …
Vertex Pharmaceuticals in the NEWS On Jul. 1, 2025, Vertex Pharmaceuticals (VRTX) announced that the European …
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer We wanted to know the …
Vertex Pharmaceuticals Simultaneous Announcements Vertex Pharmaceuticals (VRTX) announced simultaneous presentation and publication of updated data from …
Cidara Therapeutics Cidara Therapeutics uses its proprietary Cloudbreak® platform to develop novel drug-Fc conjugates (DFCs) comprising …
Exelixis in the NEWS Exelixis (EXEL) announced positive topline results from the STELLAR-303 phase 3 pivotal …
Biotechnology and biopharmaceutical firms were doing great until the day the COVID-19 pandemic changed the lives …
Alnylam Pharmaceutical's News Today is Great Before we get to the press release from Alnylam Pharmaceuticals …
Soleno Therapeutics Soleno Therapeutics (SLNO) announced that’s Marketing Authorization Application (MAA) seeking regulatory approval of Diazoxide …
Vera Therapeutics As expected, Vera Therapeutics (VERA) product Ataticept achieved proteinuria reduction in ORIGIN Phase 3 …
Akero Therapeutics Akero Therapeutics (AKRO) - a clinical-stage company developing transformational treatments for patients with serious …
Vera Therapeutics Q: What did Vera Therapeutics announce on May 6th that is more than what …
Exelixis in the NEWS Two days ago, Exelixis (EXEL) reported financial results for the first quarter …
Yesterday's Market and CytomX Therapeutics May 12, 2025 was an excellent day for many stressed countries. …
PTC Therapeutics On May 6, 2025, PTC Therapeutics (PTCT) announced a corporate update and financial results …
Alnylam Pharmaceuticals Synopsis Today, May 1, 2025 - Alnylam Pharmaceuticals (ALNY), the leading RNAi therapeutics company …
Important News from AbbVie AbbVie (ABBV) submitted a biological license application (BLA) to the United States’ …
We still believe in many outperforming biotechnology firms whose stocks are underestimated on Wall Street. We …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
